Molecular studies investigating PCa mortality and metastatic progression have suggested that the Akt–PI3K-pathway activation phosphorylates GSK-3α and/or inhibits GSK-3β activity [31–33]. The gene discussed is GSK3B; the disease is posterior cortical atrophy.